Excerpted from this Psychedelic Times article:

A study recently published in Harm Reduction Journal investigated whether patients with a psychotic disorder would accept smoking pharmaceutical cannabis variants that are less harmful than high-potency cannabis.

Results

There were very few undesired side effects from smoking the joints in the study. Psychotic-like symptoms were not observed at all, although occasional bouts of transitory nausea and dizziness did occur.

Patients reported that they accepted the pharmaceutical joints, however they did prefer their own cannabis. The main complaint the patients had about the medicinal variants was that they were significantly weaker. Apparently they didn’t taste as good either.

When asked if they would be willing to replace their own high-potency cannabis with one of the two medicinal variants, the patients did not provide clear answers. But they didn’t shut down the idea outright, offering that any potential transition would depend on two things: the experience of using the pharmaceutical cannabis on a long term basis and the options for being financially reimbursed.

While this was a small study, it found that cannabis-smoking patients with psychotic disorders appear to be willing to consume less THC and/or increase the amount of CBD, potentially even converting to medicinal variants. This would reduce the harms of consuming cannabis for this population, and further studies would need to be conducted in an effort to corroborate these findings.

Read the full study in the Harm Reduction Journal click here. Below is this study summary.  I’m not a doctor or scientist.